CRISPR 2.0 - The Next Generation of Gene Editing Therapy

Explore the groundbreaking advancements in CRISPR gene editing technology in this 51-minute talk from The Aspen Institute. Delve into the historic FDA approval of the first CRISPR-based gene therapy for sickle cell anemia and its implications. Examine the current challenges of lengthy treatment processes, severe side effects, and high costs associated with this pioneering therapy. Learn about the promising developments in next-generation CRISPR approaches, which aim to make treatments more accessible, affordable, and patient-friendly. Discover the potential impact of these advancements on treating various conditions, including blood disorders, cardiovascular diseases, cancer, and infectious diseases. Gain insights into the future of gene editing and its role in revolutionizing medical treatments as part of the Aspen Ideas: Health event, a gathering of leading thinkers tackling the most pressing health challenges.

CRISPR 2.0, the Next Generation